User: Guest  Login
Title:

Health-related quality of life (HRQoL) with adjuvant nivolumab (NIVO) vs placebo (PBO) after radical resection for high-risk muscle-invasive urothelial carcinoma (MIUC): results from the phase 3 CheckMate 274 trialep138

Document type:
Meeting Abstract
Author(s):
Gschwend, J. E.; Bajorin, D.; Galsky, M.; Broughton, E.; Braverman, J.; Koon, H.; Maira-Arce, M.; Hamilton, M.; Shi, L.; Guo, S.; Witjes, J. A.
Journal title abbreviation:
Oncology Research and Treatment
Year:
2021
Journal volume:
44 Suppl 2
Pages contribution:
263-264
Print-ISSN:
2296-5270
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX